Probucol reduces lysophosphatidylcholines in low-density lipoprotein

European Journal of Clinical Pharmacology

Volumn 55, Issue 11-12, 2000, Pages 787-792

  Yoshinari, M ^a   Shi, A H ^a   Yoshizumi, H ^b   Wakisaka, M ^a   Iwase, M ^a   Fujishima, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

Low density lipoprotein; Lysophosphatidylcholine; Probucol

Indexed keywords

LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PROBUCOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL;

EID: 0034033387     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050698     Document Type: Article

References (40)

1. Kume N, Cybulsky MI, Gimbrone MA, Jr (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules incultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138-1144
2. Cowan CL, Steffen RP (1995) Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation. Arterioscler Thromb Vasc Biol 15: 2290-2297
3. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112: 69-76
4. Sakai M, Miyazaki A, Hakamata H, Sato Y, Matsumura T, Kobori S, et al (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 269: 31430-31435
5. Sato Y, Matsumura T, Kobori S, Sasaki T, Yui S, Yamazaki M, et al (1996) Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 16: 600-605
6. Shi AH, Yoshinari M, Wakisaka M, Iwase M, Fujishima M (1999) Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. Horm Metab Res 31: 283-286
7. Watson AD, Navab M, Hama SY (1995) Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95: 774-882
8. Patel BN, Mackness MI, Harty DW, Arrol S, Boot-Handford RP, Durrington PN (1990) Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat. Biochim Biophys Acta 1035: 113-116
9. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM (1995) Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96: 2882-2891
10. Nakano T, Raines KW, Abraham JA, Lagsbrun M, Ross R (1994) Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 91: 1069-1073
11. 2+ sensitivity in alpha-toxin-permeabilized small mesenteric artery from the rat. Br J Pharmacol 117: 1238-1244
12. Carew TE, Schwene DC, Steinberg D (1987) Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725-7729
13. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hadell K, Johansson J, et al (1994) The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 74: 875-883
14. Tardiff JC, Gote G, Lesperance J, Bourassa M, Lambert J, Doucet S, et al (1997) Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 337: 365-372
15. Reaven P (1995) Dietary and pharmacologie regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 62: 1483S-1489S
16. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, et al (1997) Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radical Bio Med 22: 117-127
17. Keaney JF, Jr, Xu A, Cunningham D (1995) Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and Superoxide generation. J Clin Invest 95: 2520-2529
18. Paterson JR, Rumley AG, Oldroyd KG, Tait GW, Smellie WSA, Packard CJ, et al (1992) Probucol reduces plasma lipid peroxides in man. Atherosclerosis 97: 63-66
19. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475
20. Tamaoku K, Ueno K, Akiura K, Ohkura Y (1982) New water-soluble hydrogen donors for the enzymatic photometric determination of hydrogen peroxide, II, N-ethyl-N-(2-hydroxy-3-sulfopropyl) aniline derivatives. Chem Pharm Bull 30: 2492-2497
21. Allen JK, Hensley WJ, Nicholls AV, Whitfield JB (1979) An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem 25: 325-327
22. Banauch D, Brummer W, Ebeling W (1975) Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflussigkeiten. Z Klin Chem Klin Biochem 13: 101-107
23. Cole RA, Soeldner JS, Dunn PJ, Bunn HF (1978) A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 27: 289-301
24. Nagasaki T, Akanuma Y (1977) A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity. Clin Chim Acta 75: 371-375
25. Havel RJ, Eder HA, Bragdon JH (1955) The determination and chemical composition of ultra centrifugally separated lipoprotein in human serum. J Clin Invest 34: 1345-1353
26. Takayama M, Itoh S, Nagasaki T, Tanimizu I (1977) A new enzymatic method for determination of serum choline-containing phspholipids. Clin Chim Acta 79: 93-98
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502
28. Shi AH, Yoshinari M, Iino K, Wakisaka M, Iwase M, Fujishima M (1999) Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol. Exp Clin Endocrinol 107: 337-342
29. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994) Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014
30. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, et al (1995) Hyperglycemia-induced thrombin formation in diabetes. Diabetes 44: 924-928
31. Dobrian A, Simionescu M (1995) Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects. Biochim Biophys Acta 1270: 26-35
32. Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Bophys Acta 1044: 275-283
33. 2 cholesterolemia with abnormal cholesteryl ester transfer. Am J Cardiol 62: 66B-72B
34. Franceschini G, Sirtoli M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtoli CR (1989) Mechanisms of HDL reduction after probucol change in HDL subfractions and increased reverse cholesteryl ester transfer. Arteriosclerosis 9: 462-469
35. Parker RA, Sabrah T, Cap M, Gill BT (1995) Relation of vascular oxidative stress, alpha-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb 15: 349-358
36. Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, et al (1997) Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 30: 855-862
37. Bachem MG, Wendelin D, Schneiderhan W, Haug C, Zorn U, Gross HJ, et al (1999) Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells. Clin Chem Lab Med 37: 319-326
38. Lin MT, Su WC, Cheng ML, Cheng KS, Chang WC, Wing LH, et al (1999) The various effects of fractionated oxidized low density lipoproteins on the growth of smooth muscle cells in culture. J Biomed Sci 6: 260-268
39. Browne KF, Prystowsky EN, Heger JJ, Cerimele BJ, Fineberg N, Zipes DP (1984) Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug. Am Heart J 107: 680-684
40. Romics L, Littmann L, Laszlo Z, Fenyvesi T (1988) The effects of probucol on QT/QS2 relation and systolic time intervals. Int J Cardiol 19: 303-308